Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nuclear Medicine and Molecular Imaging|May 7, 2019
Theranostics in India: a Particularly Exquisite Concept or an Experimental ToolPartha S Choudhury, Manoj Gupta
The British Journal of Radiology|September 28, 2018
Differentiated thyroid cancer theranostics: radioiodine and beyondPartha S Choudhury, Manoj Gupta
Asia Oceania Journal of Nuclear Medicine & Biology|August 6, 2026
68Ga-FAPI PET/CT in diagnosis, staging and management of gastric carcinoma: A systematic review and meta-analysisNitin Gupta, Partha S Choudhury, Amit Rana
World Journal of Nuclear Medicine|July 4, 2017
A Comparative Study of 68Gallium-Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging for Lymph Node Staging in High Risk Prostate Cancer Patients: An Initial ExperienceManoj Gupta, Partha S Choudhury, Dibyamohan Hazarika, et al.
Hellenic Journal of Nuclear Medicine|November 18, 2015
Stimulated high serum thyroglobulin with negative whole body imaging do not warrant an aggressive diagnostic and therapeutic approach in differentiated thyroid cancer patients: A follow-up of 5 years or till recurrenceManoj Gupta, Partha S Choudhury, Sudipta Nag, et al.
World Journal of Nuclear Medicine|May 30, 2017
Can 18F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with 18F-Fluorodeoxyglucose Positron Emission Tomography?Manoj Gupta, Anupama Datta, Partha S Choudhury, et al.
Seminars in Nuclear Medicine|July 19, 2021
Impact of COVID-19 on Nuclear Medicine in AsiaHee-Seung Henry Bom, Thomas Nb Pascual, Partha S Choudhury, et al.
World Journal of Nuclear Medicine|February 2, 2013
(99m)Tc glucarate as a potential radiopharmaceutical agent for assessment of tumor viability: from bench to the bed sidePartha S Choudhury, E Savio, K K Solanki, et al.
World Journal of Nuclear Medicine|May 3, 2022
Molecular Response Assessment with Immune Adaptive PERCIST in Lung Cancer Patients Treated with Nivolumab: Is It Better Than iRECIST?Manoj Gupta, Partha S Choudhury, Parveen Jain, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2021
Changes in the global impact of COVID-19 on nuclear medicine departments during 2020: an international follow-up surveyFrancesco Giammarile, Roberto C Delgado Bolton, Noura El-Haj, et al.
Pageof 1